Salarius Pharmaceuticals Files 8-K
Ticker: DCOY · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1615219
Sentiment: neutral
Topics: material-agreement, filing, financials
TL;DR
Salarius Pharma dropped an 8-K on June 11th, looks like a material agreement is in play.
AI Summary
Salarius Pharmaceuticals, Inc. filed an 8-K on June 11, 2025, reporting a material definitive agreement and financial statements. The filing indicates a change in the company's status or operations, with the report date being June 10, 2025. The company, formerly known as Flex Pharma, Inc., is based in Houston, TX.
Why It Matters
This 8-K filing signals a significant event or agreement for Salarius Pharmaceuticals, potentially impacting its business operations, financial standing, or strategic direction.
Risk Assessment
Risk Level: medium — 8-K filings often disclose material events that can significantly impact a company's stock price and future prospects, requiring careful investor attention.
Key Numbers
- 001-36812 — SEC File Number (Identifies the company's filing with the SEC.)
- 46-5087339 — IRS Employer Identification Number (Tax identification number for the company.)
Key Players & Entities
- Salarius Pharmaceuticals, Inc. (company) — Registrant
- June 10, 2025 (date) — Date of earliest event reported
- June 11, 2025 (date) — Date of Report
- Flex Pharma, Inc. (company) — Former company name
- 2450 Holcombe Blvd. Suite X Houston, TX 77021 (location) — Principal executive offices address
FAQ
What specific material definitive agreement was entered into by Salarius Pharmaceuticals?
The filing indicates the entry into a material definitive agreement but does not specify the details of the agreement within the provided text.
What are the key financial statements being reported in this 8-K?
The filing lists 'Financial Statements and Exhibits' as an item information, but the specific financial statements are not detailed in the provided text.
When was Salarius Pharmaceuticals, Inc. formerly known as Flex Pharma, Inc.?
The date of the name change from Flex Pharma, Inc. to Salarius Pharmaceuticals, Inc. was July 30, 2014.
What is the principal executive office address for Salarius Pharmaceuticals?
The principal executive offices are located at 2450 Holcombe Blvd. Suite X, Houston, TX 77021.
What is the SIC code for Salarius Pharmaceuticals?
The Standard Industrial Classification (SIC) code for Salarius Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding Salarius Pharmaceuticals, Inc. (DCOY).